Enjoy complimentary customisation on priority with our Enterprise License!
The infusion systems market size is forecast to increase by USD 1.64 billion at a CAGR of 3.8% between 2023 and 2028. The market is witnessing significant growth due to the increasing incidence of heart failure (HF) and atherosclerosis. One of the key trends in this market is the use of infusion systems for cardiotropism, which involves the delivery of therapeutic agents directly to the heart to improve left ventricular function. Another trend is the application of retrograde venous infusion for coronary venous blockade, which can help in the delivery of gene therapy for the treatment of coronary artery obstruction. However, challenges such as cardiac recirculation and coronary artery obstruction can limit the effectiveness of infusion systems. The intense competition and pricing pressure among key players are also impacting the market dynamics. Overall, the market holds high growth potential, particularly in emerging countries, as the need for advanced medical technologies continues to increase.
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Application
7 Customer Landscape
8 Geographic Landscape
9 Drivers, Challenges, and Opportunity/Restraints
10 Competitive Landscape
11 Competitive Analysis
12 Appendix
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.